Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Three trials of indoprofen

E C Huskisson, J Scott, D L Woolf

    European Journal of Rheumatology and Inflammation
    |January 1, 1981
    PubMed
    Summary

    Indoprofen effectively reduces pain and inflammation, demonstrating superiority over placebo and comparable efficacy to aspirin and ibuprofen. Long-term use shows comparable safety to ibuprofen, though with different reasons for patient withdrawal.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Four new anti-inflammatory drugs responses and variations.

    The Medical journal of Malaysia·2022
    Same author

    Catecholamine excretion and pain.

    British journal of clinical pharmacology·2012
    Same author

    Indomethacin or amylobarbitone sodium for sleep in rheumatoid arthritis, with some observations on the use of sequential analysis.

    British journal of clinical pharmacology·2012
    Same author

    Modern management of mild-to-moderate joint pain due to osteoarthritis: a holistic approach.

    The Journal of international medical research·2010
    Same author

    Glucosamine and chondroitin for osteoarthritis.

    The Journal of international medical research·2008
    Same author

    Nimesulide, a balanced drug for the treatment of osteoarthritis.

    Clinical and experimental rheumatology·2001

    Area of Science:

    • Pharmacology
    • Clinical Trials
    • Drug Efficacy

    Background:

    • Indoprofen is a non-steroidal anti-inflammatory drug (NSAID).
    • Previous studies have documented various properties of indoprofen.

    Purpose of the Study:

    • To document the analgesic and anti-inflammatory properties of indoprofen.
    • To assess the safety and efficacy of indoprofen compared to placebo, aspirin, and ibuprofen.

    Main Methods:

    • Three clinical trials were conducted.
    • Indoprofen (200 mg) was evaluated for analgesic effects against placebo and aspirin (700 mg).
    • Indoprofen (200 mg four times daily) was evaluated for anti-inflammatory effects against ibuprofen (300 mg four times daily) and placebo.

    Main Results:

    • Indoprofen was superior to placebo and as effective as aspirin for analgesia.
    • Indoprofen demonstrated superior anti-inflammatory effects compared to ibuprofen and placebo.
    • Treatment effects plateaued within 24 hours of administration.
    • Long-term safety was confirmed, with side effect incidence similar to ibuprofen.
    • Withdrawal rates were equal, but reasons differed: lack of effect for ibuprofen, gastric issues for indoprofen.

    Conclusions:

    • Indoprofen is an effective analgesic and anti-inflammatory agent.
    • Indoprofen exhibits a favorable safety profile comparable to ibuprofen, with distinct reasons for patient withdrawal.
    • The drug's therapeutic effect is achieved rapidly and plateaus within 24 hours.

    Related Experiment Videos